1- AFSSAPS, HAS. Traitement médicamenteux du diabète de type 2. Actualisation. Recommandations. Novembre 2006.
http://www.has-sante.fr/portail/upload/docs/application/pdf/recos_diabe…
2- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837-53.
3- Holman RR, Paul SK, Bethel MA et al. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. N Engl J Med 2008;359:1577-89.
4- Gerstein HC, Miller ME, Byington RP et al. The Action to Control Cardiovascular Risk in Diabetes Study Grou. Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med 2008;358:2545-59.
5- The ADVANCE Collaborative Group. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2008;358:2560-72.
6- Duckworth W, Abraira C, Moritz t et al, for the VADT Investigators. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. N Engl J Med 2009;360: 129-39.
7- Halimi S. Vers de nouvelles recommandations de traitement du diabète de type 2 ? Point de vue d’un expert. Rev Prat 2010; 60: 504-9
8- AFSSAPS, HAS. Traitement médicamenteux du diabète de type 2. Actualisation. Argumentaire. Novembre 2006.
http://www.has-sante.fr/portail/upload/docs/application/pdf/argum_diabe…
9- Nathan DM, Buse JB, Davidson MB, et al. American Diabetes Association. European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203.
Mise au point
Les urgences psychiatriques en médecine générale
Étude et pratique
Mortalité liée au tabac, le sevrage bénéfique quel que soit l’âge
Cas clinique
Le kyste osseux anévrismal
Recommandation
Le RGO du nourrisson